ArticleJournal of gynecologic oncology2024
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Takahiro Nozaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it